HELUS PHARMA COMPLETES ENROLLMENT IN PHASE 3 APPROACH STUDY OF HLP003 IN ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER AHEAD OF SCHEDULE

Reuters · 1d ago

Please log in to view news